Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy

Historically, salvage chemoimmunotherapy with consolidative autologous hematopoietic stem cell transplantation (ASCT) was the only potentially curative therapeutic option for patients with relapsed/refractory large B-cell lymphoma (LBCL). Treatment options were few and outcomes poor for patients who...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tamara K. Moyo, Rakhee Vaidya
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-08-01
Saila:	Frontiers in Oncology
Gaiak:	relapsed large B-cell lymphoma (LBCL) CAR T-cell therapy autologous stem cell transplant (ASCT) tisagenlecleucel axicabtagene ciloleucel lisocabtagene maraleucel
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1397186/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!